Eurax Lotion is a topical antipruritic and scabicidal medication used to relieve itching and treat scabies infestations. Suitable for adults and certain children when directed, it soothes irritated skin while addressing mites responsible for scabies. The lotion is applied directly to clean, dry skin and is typically used in short courses for scabies or as needed for pruritus. Always avoid eyes, mucous membranes, and broken skin. Although generally well tolerated, it can cause local irritation in some users. Guidance from a healthcare professional helps tailor safe use, especially for pregnant, breastfeeding, or pediatric patients, and those with sensitivities.
Eurax Lotion contains crotamiton 10%, a topical agent with two primary roles: relieving pruritus (itching) and serving as a scabicide for the treatment of scabies. For scabies, it is applied to the skin to help eliminate Sarcoptes scabiei mites and alleviate the relentless itch that often persists even after mites are cleared. For non-scabetic itching, Eurax Lotion can be used on localized areas to soothe irritation from conditions like insect bites or certain itchy dermatoses, as advised by a healthcare professional.
While crotamiton is an established option, treatment decisions should consider local guidelines. In many regions, 5% permethrin is considered a first-line scabies treatment, with crotamiton used when permethrin is unsuitable or unavailable, or when an antipruritic effect is especially valuable. Regardless of the agent chosen, success depends on correct application and environmental hygiene measures to prevent reinfestation.
For scabies in adults, apply Eurax Lotion to clean, dry skin from the neck down, covering the entire surface including between fingers and toes, under nails, soles, and all skin folds. Trim nails short and use a soft brush to get product beneath the nails. A common regimen is one thorough application followed by a second application 24 hours later, then a full bath or shower 48 hours after the second application to wash the product off. Some clinicians direct a different schedule; always follow the specific regimen provided by your prescriber or the product label.
For pruritus not due to scabies, a thin layer can be applied to affected areas 3–4 times daily as needed, taking care not to use on broken, inflamed, or oozing skin. Do not use occlusive dressings unless directed, as this can increase absorption and irritation. Avoid contact with eyes, mouth, nose, genital mucosa, and damaged skin. If scabies involves the scalp in young children (uncommon in adults), a clinician may advise careful application to the hairline, scalp, temples, and forehead while avoiding eyes and mouth; pediatric use should always be clinician-directed.
General treatment tips that improve results: bathe and thoroughly dry the skin before the first application; change into clean clothes afterward; launder recently used clothing, towels, bedding, and sleepwear in hot water and high heat dry cycles, or seal items that cannot be washed in a plastic bag for at least 72 hours. Treat close contacts at the same time per clinical guidance, even if they do not yet itch. Be aware that itching can persist for 2–4 weeks after successful scabies therapy due to post-scabetic dermatitis; this does not always mean treatment failure.
Use Eurax Lotion only on intact skin. Do not apply to raw, oozing, severely inflamed, or broken areas, and avoid eyes, lips, nostrils, genital mucosa, and the ear canal. If accidental contact occurs, rinse thoroughly with water. Because some formulations contain alcohols or solvents, allow the lotion to dry fully before dressing and keep away from open flames or smoking during application and drying. Wash hands well after use unless treating the hands; if you are treating the hands, avoid washing them for several hours to maintain contact time.
Special populations warrant added care. Children have more permeable skin and higher surface-area-to-weight ratios; use in young children should be directed by a clinician, and infants require particular caution. During pregnancy and breastfeeding, discuss risks and benefits with a healthcare provider; if used while nursing, avoid applying to the breast to prevent accidental ingestion by the infant. Individuals with a history of contact dermatitis, fragrance sensitivity, or reactions to excipients should review the ingredient list and patch-test a small area if advised by a clinician.
Eurax Lotion is contraindicated in anyone with known hypersensitivity to crotamiton or any component of the formulation. Do not use on acutely weeping or severely inflamed dermatoses, on open wounds, or in patients with a documented allergic contact dermatitis to similar topical bases or fragrances present in the product. If signs of a true allergic reaction occur—such as widespread rash, swelling, hives, or difficulty breathing—stop using the lotion and seek medical attention promptly.
Most people tolerate crotamiton well, but local skin reactions can occur. These may include transient burning, stinging, tingling, itching, redness, dryness, or mild irritation at the application site. Less commonly, contact dermatitis (allergic or irritant) can develop, presenting with intense redness, swelling, blistering, or worsening rash beyond the treated areas. Because scabies itself causes persistent itch, differentiating side effects from ongoing post-scabetic pruritus can be challenging; a clinician can help determine whether symptoms represent treatment response, residual inflammation, or sensitivity to the product. If severe irritation occurs, wash the product off and contact a healthcare provider for alternatives or supportive care.
Clinically significant drug–drug interactions are uncommon because Eurax Lotion acts locally on the skin. However, concurrent use with other topical scabicides (such as permethrin or lindane) without clinician guidance is discouraged, as layering products can increase irritation and confound effectiveness. Strong keratolytics, exfoliants, or harsh cleansers may heighten irritation or alter absorption; use gentle skin care during therapy. Topical corticosteroids may ease inflammation and itch but can also mask signs of ongoing infestation—use them only as directed by a clinician. Avoid occlusive dressings unless specifically instructed, as occlusion increases absorption and may intensify adverse reactions.
If you miss a scheduled application during a scabies regimen, apply as soon as you remember on the same day. If it is close to the time of your next application, skip the missed dose and continue with the regular schedule. Do not double-apply to “catch up,” as this may increase skin irritation without improving results. For antipruritic use, simply apply when needed while respecting maximum frequency directed by your clinician or the product labeling.
Topical overdose is unlikely to cause systemic toxicity but can lead to significant local irritation, burning, or dermatitis; wash the skin thoroughly with mild soap and water and seek medical advice if symptoms persist. Accidental ingestion of crotamiton can be dangerous, with potential gastrointestinal upset, drowsiness, or other systemic effects—if swallowed, call your local poison control center or seek emergency care immediately. Keep Eurax Lotion out of reach of children and pets, secure the cap tightly after each use, and never transfer the product to an unlabeled container.
Store Eurax Lotion at controlled room temperature, typically 20–25°C (68–77°F), away from excessive heat, direct sunlight, and moisture. Do not freeze. Because some formulations may be flammable until dry, keep away from open flames and ignition sources during and shortly after application. Replace the cap tightly to prevent evaporation and contamination. Always check expiration dates and discard any lotion that has changed color, separated, or developed an unusual odor.
Availability and prescription requirements for crotamiton products can vary. HealthSouth Rehabilitation Hospital of Las Vegas offers a legal and structured pathway to buy Eurax Lotion without prescription on hand by integrating a brief, compliant clinical screening into the checkout process. Your responses are reviewed by a licensed professional who determines suitability and, if appropriate, authorizes the medication through a partner prescriber—eliminating the need for a traditional, prior paper prescription while staying within U.S. telehealth and pharmacy regulations. Orders are dispensed by a licensed pharmacy, packaged discreetly, and shipped promptly. This approach protects patient safety, ensures appropriate use, and provides convenient access for adults who meet eligibility criteria.
Eurax Lotion contains crotamiton, an antipruritic and scabicidal agent that calms nerve signals involved in itching and helps kill scabies mites when used as directed.
It is used to relieve itching from conditions like eczema, dermatitis, and insect bites, and to treat scabies infestations when prescribed.
Apply a thin layer to the itchy area 2–3 times daily, gently rub in, and wash hands after use; avoid broken skin, eyes, and mucous membranes.
Follow your clinician’s plan; a common regimen is full-body application from the neck down (including skin folds, groin, under nails), repeat after 24 hours, then wash off 48 hours after the last application.
Many people feel relief within minutes to a few hours; scabies-related itch can persist for 2–4 weeks after successful treatment due to lingering inflammation.
Do not use in young children unless advised by a clinician; safety is not established in toddlers and infants, and alternatives like permethrin are usually preferred.
Data in pregnancy are limited; permethrin is generally preferred. If used during breastfeeding, avoid application to the breast and wash hands before nursing.
Do not apply to eyes, mouth, inside the nose, on mucous membranes, or on raw, oozing, or severely inflamed skin; avoid covering with airtight dressings.
Possible effects include mild burning, stinging, redness, dryness, or contact dermatitis; stop and wash off if severe irritation or rash occurs and seek medical advice.
Avoid the eyes and lips; for scabies, apply to all skin as directed (including groin and between fingers/toes) but avoid mucosal surfaces unless your clinician instructs otherwise.
It is not reliably ovicidal, which is why repeat applications and treating close contacts and the environment are important.
If an area is washed within the treatment period, reapply to that area; for scabies, keep the medication on for the full prescribed interval before bathing.
You can often combine with oral antihistamines or short courses of mild topical steroids for inflammation, but avoid layering multiple topical irritants on the same site.
On treatment days, wash bedding, towels, and recently worn clothes in hot water and high heat dry; seal unwashables in a bag for at least 72 hours; vacuum soft furniture.
Availability varies by country; in some places it is over the counter for itch and prescription-only for scabies—check local guidance.
Use the smallest amount for the shortest time needed; if itching persists beyond 7 days or recurs, see a healthcare professional.
Rinse thoroughly with water for several minutes and seek medical advice if irritation persists.
No; occlusion increases absorption and irritation risk.
Meaningful drug–drug interactions are unlikely, but combining with other topical irritants (like strong acids, retinoids, or alcohol-heavy preparations) can increase irritation.
Keep at room temperature, capped tightly, away from heat and children; do not freeze.
Permethrin 5% is first-line in most guidelines with higher cure rates; Eurax (crotamiton) is an alternative when permethrin is not tolerated or available.
Eurax has dedicated antipruritic action and often relieves itch faster; permethrin kills mites effectively but may not soothe itch on its own.
Eurax is generally better tolerated; benzyl benzoate can be quite irritating, especially for children, though it is effective and inexpensive.
Sulfur 5–10% is considered safe in pregnancy and infants but is messy and odorous; Eurax has limited pregnancy data and is not recommended for young infants without specialist advice.
Oral ivermectin is convenient for outbreaks, crusted scabies, or when topical use is impractical, but it’s not recommended in pregnancy; Eurax is topical and can be used when permethrin is unsuitable.
Hydrocortisone reduces inflammation underlying eczema; Eurax mainly targets itch. Many clinicians use hydrocortisone for flares and may add Eurax short-term for itch if appropriate.
Both reduce itch; pramoxine is a topical anesthetic helpful for localized itch, while Eurax also has scabicidal activity, making it useful if scabies is a concern.
Calamine is soothing but modest; Eurax provides stronger antipruritic relief and has scabicidal properties, though calamine may be preferred for very sensitive skin.
Lindane is largely avoided due to neurotoxicity risks; Eurax has a better safety profile but is less effective than permethrin.
Do not apply them at the same time; complete the permethrin application and wash it off as directed, then use Eurax later for residual itch only if your clinician agrees.
Benzyl benzoate is often cheaper but more irritating; Eurax may cost more or require a prescription, so the best choice balances tolerance, access, and clinician guidance.
Oral antihistamines may aid sleep and reduce itch perception; they can be combined with Eurax (applied topically) if approved by your clinician.
Permethrin is generally preferred and well-studied; Eurax may be considered only if benefits outweigh risks and with medical supervision.